1.22% 0.3969

Tg Therapeutics Inc (TGTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TGTX Giù? Forum Previsione Frazionamento azionario

Tg Therapeutics Inc Azioni (TGTX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	16.79% 141.15	120.86	108.19	83.88	73.47
Cost Of Revenue	21.86% 18.94	15.54	15.40	9.341	8.304
Gross Profit	16.04% 122.21	105.31	92.79	74.54	65.16
Operating Expenses	9.64% 87.37	96.69	62.84	62.10	56.35
Benefits Costs and Expenses	4.47% 110.23	115.39	82.73	79.61	66.92
Costs And Expenses	5.28% 106.31	112.23	78.24	71.44	64.65
Operating Income/Loss	304.12% 34.84	8.622	29.95	12.43	8.816
Nonoperating Income/Loss	24.38% -3.923	-3.154	-4.496	-8.166	-2.265
Income/Loss From Continuing Operations Before Tax	465.47% 30.92	5.468	25.45	4.268	6.551
Income Tax Expense/Benefit	569.85% 2.733	0.408	2.122	0.388	-0.328
Income/Loss From Continuing Operations After Tax	457.06% 28.19	5.06	23.33	3.88	6.879
Net Income/Loss	457.06% 28.19	5.06	23.33	3.88	6.879
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.04% 146.74	146.68	-0.0249	145.10	144.73
Diluted Average Shares	0.13% 162.56	162.77	-0.0309	160.71	159.42
Basic Earnings Per Share	533.33% 0.19	0.03	0.16	0.03	0.05
Diluted Earnings Per Share	466.67% 0.17	0.03	0.15	0.02	0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.32

0.98%

GMAB

$27.46

0.29%

SMMT

$25.74

7.94%

BNTX

$110.50

7.16%

INSM

$143.93

0.80%

ONC

$339.41

6.39%